Patient Guide: A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 76 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06745323
Status: 🟢 Enrolling Now
Condition: Small Cell Lung Cancer (SCLC)
Phase: PHASE2

Where You Can Participate

This study is available at 76 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Plainville, Connecticut
  • • Orlando, Florida
  • • And 73 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC - Join Clinical Trial NCTNCT06745323

How to Join This Clinical Trial - NCTNCT06745323

Learn how to participate in this PHASE2 trial studying an investigational therapy for Small Cell Lung Cancer (SCLC). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Small Cell Lung Cancer (SCLC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Small Cell Lung Cancer (SCLC)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06745323 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 76 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90095 - United States

Status: RECRUITING

Clinical Research Site

Plainville, Connecticut 06062 - United States

Status: RECRUITING

Clinical Research Site

Orlando, Florida 32804 - United States

Status: RECRUITING

Clinical Research Site

Rockford, Illinois 61108 - United States

Status: RECRUITING

Clinical Research Site

Saint Paul, Minnesota 55101 - United States

Status: RECRUITING

Clinical Research Site

Albany, New York 12206 - United States

Status: RECRUITING

Clinical Research Site

Durham, North Carolina 27705 - United States

Status: RECRUITING

Clinical Research Site

Pinehurst, North Carolina 28374 - United States

Status: RECRUITING

Clinical Research Site

Sayre, Pennsylvania 18840 - United States

Status: RECRUITING

Clinical Research Site

Fairfax, Virginia 22031 - United States

Status: RECRUITING

And 66 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Small Cell Lung Cancer (SCLC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships